Regulation And Legal
Rubicon Receives 2 US FDA Observations at Pithampur
Rubicon discloses US FDA inspection results for its Pithampur facility, conducted from June 29 to July 3, 2026.
The inspection concluded with a Form 483 containing 2 procedural observations, with no d
